Advanced search
Publication Cover
OncoImmunology Volume 6, 2017 - Issue 4
Submit an article Journal homepage
1,395
Views
19
CrossRef citations to date
0
Altmetric
Original Research

Adaptive T cell responses induced by oncolytic Herpes Simplex Virus-granulocyte macrophage-colony-stimulating factor therapy expanded by dendritic cell and cytokine-induced killer cell adoptive therapy

Jun RenBeijing Key Lab for Therapeutic Cancer Vaccines, Capital Medical University Cancer Center, Beijing Shijitan Hospital, Capital Medical University, Beijing, China;Department of Surgery, Duke University Medical Center, Durham, NC, USA
,
William R. GwinDepartment of Surgery, Duke University Medical Center, Durham, NC, USA
,
Xinna ZhouBeijing Key Lab for Therapeutic Cancer Vaccines, Capital Medical University Cancer Center, Beijing Shijitan Hospital, Capital Medical University, Beijing, China
,
Xiaoli WangBeijing Key Lab for Therapeutic Cancer Vaccines, Capital Medical University Cancer Center, Beijing Shijitan Hospital, Capital Medical University, Beijing, China
,
Hongyan HuangBeijing Key Lab for Therapeutic Cancer Vaccines, Capital Medical University Cancer Center, Beijing Shijitan Hospital, Capital Medical University, Beijing, China
,
Ni JiangBeijing Key Lab for Therapeutic Cancer Vaccines, Capital Medical University Cancer Center, Beijing Shijitan Hospital, Capital Medical University, Beijing, China
,
Lei ZhouBeijing Key Lab for Therapeutic Cancer Vaccines, Capital Medical University Cancer Center, Beijing Shijitan Hospital, Capital Medical University, Beijing, China
,
Pankaj AgarwalDepartment of Surgery, Duke University Medical Center, Durham, NC, USA
,
Amy HobeikaDepartment of Surgery, Duke University Medical Center, Durham, NC, USA
,
Erika CrosbyDepartment of Surgery, Duke University Medical Center, Durham, NC, USA
,
Zachary C. HartmanDepartment of Surgery, Duke University Medical Center, Durham, NC, USA
,
Michael A. MorseDepartment of Medicine, Duke University Medical Center, Durham, NC, USA
,
Kevin H. EngDepartment of Biostatistics and Bioinformatics, Roswell Park Cancer Institute, Buffalo, NY, USA
&
H. Kim LyerlyDepartment of Surgery, Duke University Medical Center, Durham, NC, USACorrespondence[email protected]
 show all
Article: e1264563 | Received 29 Jul 2016, Accepted 18 Nov 2016, Published online: 05 Apr 2017

Citations (19)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Guoliang Qiao, Xiaoli Wang, Xinna Zhou, Michael A. Morse, Jiangping Wu, Shuo Wang, Yuguang Song, Ni Jiang, Yanjie Zhao, Lei Zhou, Jing Zhao, Yan Di, Lihong Zhu, Amy Hobeika, Jun Ren & Herbert Kim Lyerly. (2019) Immune correlates of clinical benefit in a phase I study of hyperthermia with adoptive T cell immunotherapy in patients with solid tumors. International Journal of Hyperthermia 36:sup1, pages 74-82.
Read now
Jenny Sprooten, Jolien Ceusters, An Coosemans, Patrizia Agostinis, Steven De Vleeschouwer, Laurence Zitvogel, Guido Kroemer, Lorenzo Galluzzi & Abhishek D. Garg. (2019) Trial watch: dendritic cell vaccination for cancer immunotherapy. OncoImmunology 8:11.
Read now
Jonathan G. Pol, Sarah Lévesque, Samuel T. Workenhe, Shashi Gujar, Fabrice Le Boeuf, Derek R. Clements, Jean-Eudes Fahrner, Laetitia Fend, John C. Bell, Karen L. Mossman, Jitka Fucikova, Radek Spisek, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2018) Trial Watch: Oncolytic viro-immunotherapy of hematologic and solid tumors. OncoImmunology 7:12.
Read now

Articles from other publishers (16)

Shijie Duan, Shuhang Wang, Lei Qiao, Xinbo Yu, Nan Wang, Liting Chen, Xinyuan Zhang, Xu Zhao, Hongyu Liu, Tianye Wang, Ying Wu, Ning Li & Funan Liu. (2023) Oncolytic Virus‐Driven Biotherapies from Bench to Bedside. Small 19:23.
Crossref
Kiira Kalke, Julius Orpana, Tuomas Lasanen, Olaya Esparta, Liisa M. Lund, Fanny Frejborg, Tytti Vuorinen, Henrik Paavilainen & Veijo Hukkanen. (2022) The In Vitro Replication, Spread, and Oncolytic Potential of Finnish Circulating Strains of Herpes Simplex Virus Type 1. Viruses 14:6, pages 1290.
Crossref
Qian Zhu, Guoliang Qiao, Lefu Huang, Chang Xu, Deliang Guo, Shuo Wang, Jing Zhao, Yuguang Song, Bing Liu, Zheng Chen, Zhiyong Yang & Yufeng Yuan. (2022) Restored CD8+PD-1+ T Cells Facilitate the Response to Anti-PD-1 for Patients With Pancreatic Ductal Adenocarcinoma. Frontiers in Oncology 12.
Crossref
ChuanLiang Cui, Xuan Wang, Bin Lian, Qing Ji, Li Zhou, Zhihong Chi, Lu Si, Xinan Sheng, Yan Kong, Jiayi Yu, Siming Li, Lili Mao, Bixia Tang, Jie Dai, Xieqiao Yan, Xue Bai, Robert Andtbacka & Jun Guo. (2022) OrienX010, an oncolytic virus, in patients with unresectable stage IIIC–IV melanoma: a phase Ib study. Journal for ImmunoTherapy of Cancer 10:4, pages e004307.
Crossref
Jiayi Zeng, Xiangxue Li, Max Sander, Haipeng Zhang, Guangmei Yan & Yuan Lin. (2021) Oncolytic Viro-Immunotherapy: An Emerging Option in the Treatment of Gliomas. Frontiers in Immunology 12.
Crossref
Chongxian Pan, Hongtao Liu, Elizabeth Robins, Wenru Song, Delong Liu, Zihai Li & Lei Zheng. (2020) Next-generation immuno-oncology agents: current momentum shifts in cancer immunotherapy. Journal of Hematology & Oncology 13:1.
Crossref
Linkang Cai, Han Hu, Haixiao Duan, Yuying Li, Zongxing Zou, Kailun Luo, Ziyi Zhang, Junhan Yang, Jing Jin, Ying Chen, Zonghuang Ke, Zongyao Fang, Qiong Liu, Xiaoqian Hong, Sheng Hu & Binlei Liu. (2020) The construction of a new oncolytic herpes simplex virus expressing murine interleukin‐15 with gene‐editing technology. Journal of Medical Virology 92:12, pages 3617-3627.
Crossref
Xinna Zhou, Guoliang Qiao, Jun Ren, Xiaoli Wang, Shuo Wang, Siyu Zhu, Yanhua Yuan, Michael A. Morse, Amy Hobeika & Herbert Kim Lyerly. (2020) Adoptive immunotherapy with autologous T-cell infusions reduces opioid requirements in advanced cancer patients. Pain 161:1, pages 127-134.
Crossref
Lefu Huang, Guoliang Qiao, Michael Morse, Xiaoli Wang, Xinna Zhou, Jiangping Wu, Amy Hobeika, Jun Ren & Herbert Lyerly. (2019) Predictive significance of T cell subset changes during ex�vivo generation of adoptive cellular therapy products for the treatment of advanced non‑small cell lung cancer. Oncology Letters.
Crossref
Guoliang Qiao, Xiaoli Wang, Lei Zhou, Xinna Zhou, Yuguang Song, Shuo Wang, Lei Zhao, Michael A. Morse, Amy Hobeika, Jin Song, Xin Yi, Xuefeng Xia, Jun Ren & Herbert Kim Lyerly. (2019) Autologous Dendritic Cell-Cytokine Induced Killer Cell Immunotherapy Combined with S-1 Plus Cisplatin in Patients with Advanced Gastric Cancer: A Prospective Study. Clinical Cancer Research 25:5, pages 1494-1504.
Crossref
William R. Gwin, Mary L. Disis & Erika Ruiz-Garcia. 2019. Translational Research and Onco-Omics Applications in the Era of Cancer Personal Genomics. Translational Research and Onco-Omics Applications in the Era of Cancer Personal Genomics 117 129 .
Neil S. Forbes, Robert S. Coffin, Liang Deng, Laura Evgin, Steve Fiering, Matthew Giacalone, Claudia Gravekamp, James L. Gulley, Hal Gunn, Robert M. Hoffman, Balveen Kaur, Ke Liu, Herbert Kim Lyerly, Ariel E. Marciscano, Eddie Moradian, Sheryl Ruppel, Daniel A. Saltzman, Peter J. Tattersall, Steve Thorne, Richard G. Vile, Halle Huihong Zhang, Shibin Zhou & Grant McFadden. (2018) White paper on microbial anti-cancer therapy and prevention. Journal for ImmunoTherapy of Cancer 6:1.
Crossref
Nikolas Tim Martin & John Cameron Bell. (2018) Oncolytic Virus Combination Therapy: Killing One Bird with Two Stones. Molecular Therapy 26:6, pages 1414-1422.
Crossref
Colleen S. Curran, Avraham Rasooly, Min He, Ben Prickril, Magdelena Thurin & Elad Sharon. (2018) Report on the NCI Microbial-Based Cancer Therapy Conference. Cancer Immunology Research 6:2, pages 122-126.
Crossref
Ding WeiJing XuXin-Yuan LiuZhi-Nan ChenHuijie Bian. (2018) Fighting Cancer with Viruses: Oncolytic Virus Therapy in China. Human Gene Therapy 29:2, pages 151-159.
Crossref
Ni Jiang, Guoliang Qiao, Xiaoli Wang, Michael A. Morse, William R. Gwin, Lei Zhou, Yuguang Song, Yanjie Zhao, Feng Chen, Xinna Zhou, Lefu Huang, Amy Hobeika, Xin Yi, Xuefeng Xia, Yanfang Guan, Jin Song, Jun Ren & H. Kim Lyerly. (2017) Dendritic Cell/Cytokine-Induced Killer Cell Immunotherapy Combined with S-1 in Patients with Advanced Pancreatic Cancer: A Prospective Study. Clinical Cancer Research 23:17, pages 5066-5073.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.